BEAM Beam Tx: Bozor kapitallashuvining balans qiymatiga nisbati
Beam Therapeutics Inc. (BEAM) ning narxlar dinamikasida aks etgan bozor holati FDA ning qat'iy nazorati va patent cheklovlarining ta'sirini ko'rsatmoqda, bunda ko'rsatkich 2.40 darajasida turibdi. Biznes dasturi erta bosqichdagi sinovlarda nuqtali mutatsiyalarni yo'q qilish uchun "genetik o'chirg'ich" yaratishga yo'naltirilgan. Kompaniyaga tegishli ustunlik kodni ikki zanjirli uzilishlarsiz xavfsiz modifikatsiya qilishga asoslangan bo'lib, bu terapiyani yanada samaraliroq qiladi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_BEAM_-_Beam-Therapeutics-Inc._-_Capitalization-to-Book-Value-Ratio "beamtx.com (BEAM) - Bozor qiymatining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha | 👁️GURU.Markets👁️")
BEAM (Beam Therapeutics Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Beam Therapeutics Inc.|BEAM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Beam Therapeutics Corp|BEAM - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Beam Therapeutics Corp|BEAM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi Beam Therapeutics
Kompaniyaning dastlabki tahlili:Beam Therapeutics Inc. - BEAM
Ushbu ko'rsatkich aktivlarning bozor qiymati va ularning haqiqiy balans qiymati o'rtasidagi farqni aks ettirib, bozor shoklari paytida biznesning xavfsizlik zaxirasini real vaqt rejimida baholash imkonini beradi. GURU.Markets platformasida bozor kapitalizatsiyasining balans qiymatiga nisbatini tahlil qilish orqali investor Beam Therapeutics Inc. (BEAM) kompaniyasining barqarorligini aniqlaydi, uning yuqori aniqlikdagi genom tahrirlash bazasi va sog'liqni saqlash gigantlari bilan hamkorligi aksiyalar qiymatini tebranishlardan himoya qilish uchun asos yaratadi.
Toʻgʻridan-toʻgʻri raqobatchilar
TEM (Tempus Labs) - Bozor qiymatining balans qiymatiga nisbati|qiagen.com (QGEN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|Bozor kapitallashuvining balans qiymatiga nisbati ultragenyx.com RARE|SRPT - Bozor kapitallashuvining balans qiymatiga nisbati|TWST - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TXG|Intellia Corp (NTLA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|STOK (Stoke Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati BLFS|Bozor qiymatining balans qiymatiga nisbati WVE (Wave Life Sciences Ltd.)|Kapitallashuvning sof aktivlarga nisbati Maze Therapeutics, Inc. MAZE|Kapitallashuvning sof aktivlarga nisbati Sionna Pharma|PRME - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati Taysha Gene Therapies TSHA|QURE - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati MeiraGTx MGTX|REGENXBIO Inc (RGNX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati SLDB (Solid Bio)|Bozor qiymatining balans qiymatiga koeffitsiyenti OCGN|Pacific Biosciences (PACB) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati benitec.com (BNTC)|Bozor kapitallashuvining balans qiymatiga nisbati DSGN (Design Therapeutics, Inc.)|Rocket Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati 4D Molecular Therapeutics Inc|LXEO - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati KRRO|Bozor qiymatining balans qiymatiga koeffitsiyenti editasmedicine.com|SLN (Silence Therapeutics plc) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ProQR Therapeutics NV (PRQR)|Kapitallashuvning sof aktivlarga nisbati Codexis, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori Sangamo BioSciences (SGMO)|Bozor kapitallashuvining balans qiymatiga nisbati NAUT|Balans qiymatiga nisbatan bozor kapitallashuvi metagenomi.co MGX|DTIL: Bozor kapitallashuvining balans qiymatiga nisbati|GBIO: Kapitallashuvning sof aktivlarga nisbati|Boundless Bio, Inc - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Exicure|IMNN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RXi Pharmaceuticals|MBIO (Mustang Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|BLUE: Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|Singular Genomics Systems, Inc. (OMIC) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc|Bozor qiymatining balans qiymatiga nisbati Syros Pharmaceuticals, Inc|Telesis Bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)